Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2003CirculationOpen Access

Acute Pulmonary Embolism: Part II

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

Samuel Z. GoldhaberSamuel Z. GoldhaberVascular / Pulmonary VascularCEC. Gregory ElliottVascular Medicine

Discussion

Loading...

Member takes

Implication

May favor formal scores over gestalt for PE risk stratification; leaves open prospective outcome validation before practice change.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Goldhaber et al. (2003) studied this question.

synapsesocial.com/papers/6a198bec443d3ecd7cdebb63https://doi.org/10.1161/01.cir.0000098427.74047.42

Topics

Pulmonary embolism
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty2002 · 211 citations
  2. 2Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy2002 · 1,052 citations
  3. 3Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer2003 · 2,542 citations
  4. 4Short-Term Clinical Outcome of Patients With Acute Pulmonary Embolism, Normal Blood Pressure, and Echocardiographic Right Ventricular Dysfunction2000 · 844 citations
  5. 5A Clinical Decision Support System for Prevention of Venous Thromboembolism2000 · 243 citations